Newsroom

ORLANDO, Fla.--(BUSINESS WIRE)--New LinkedIn Research Initiative Will Examine Streaming, Telecommunications, Satellite, D2D/D2M, Broadcasting, Advertising and Digital Commerce...

MILANO--(BUSINESS WIRE)--Zambon annuncia oggi che la Commissione Europea (CE) ha concesso l'autorizzazione all'immissione in commercio di Hopledo® (levodopa/carbidopa a rilascio modificato) per il trattamento dei pazienti adulti affetti da Malattia di Parkinson e fluttuazioni motorie da moderate a severe non adeguatamente controllate con regimi terapeutici orali a base di levodopa e inibitori della dopa decarbossilasi (DDC). Zambon prevede di avviare l'introduzione graduale di Hopledo® nei merc...

MILAN, Italie--(BUSINESS WIRE)--Zambon annonce aujourd’hui que la Commission européenne a accordé une autorisation de mise sur le marché à Hopledo® (lévodopa/carbidopa à libération modifiée) pour le traitement des patients adultes atteints de la maladie de Parkinson et présentant des fluctuations motrices modérées à sévères, insuffisamment contrôlées malgré un traitement oral à base de lévodopa associé à un inhibiteur de la DDC (Dopa décarboxylase).Zambon prévoit la mise à disposition progressi...

MILAAN, Italië--(BUSINESS WIRE)--Zambon kondigt vandaag aan dat de Europese Commissie (EC) een vergunning voor het in de handel brengen heeft verleend voor Hopledo® (levodopa/carbidopa met gereguleerde afgifte) voor de behandeling van volwassen patiënten met de ziekte van Parkinson en matige tot ernstige motorische fluctuaties die onvoldoende gestabiliseerd zijn met orale behandelschema’s op basis van levodopa/dopa-decarboxylase (DDC)-remmers. Zambon bereidt een gefaseerde introductie van Hople...

MILAN, Italy--(BUSINESS WIRE)--Zambon announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa)...

MILÁN, Italia--(BUSINESS WIRE)--Zambon ha anunciado hoy que la Comisión Europea (CE) ha concedido la autorización de comercialización de Hopledo® (levodopa/carbidopa de liberación modificada) para el tratamiento de pacientes adultos con enfermedad de Parkinson, y fluctuaciones motoras moderadas a graves que no han logrado una estabilización suficiente con regímenes terapéuticos basados en levodopa oral/inhibidores de la dopa descarboxilasa (DDC). Zambon prevé comenzar la introducción gradual de...

MILÃO, Itália--(BUSINESS WIRE)--A Zambon anunciou hoje que a Comissão Europeia (CE) concedeu a autorização de introdução no mercado de Hopledo® (levodopa/carbidopa de libertação modificada) para o tratamento de adultos com doença de Parkinson e flutuações motoras moderadas a graves que não alcançaram um controlo adequado da doença com esquemas terapêuticos baseados em levodopa oral e inibidores da dopa descarboxilase (DDC). A Zambon prevê iniciar a introdução gradual desta formulação nos mercad...

ATHENS, Greece--(BUSINESS WIRE)--Piraeus Bank S.A. (“Piraeus” or the “Bank”) announces that, it has successfully completed the pricing of a new €500 million Senior Preferred Bond (the “Bond”) with an annual fixed coupon at 4.00%, attracting the interest of a large number of institutional investors. The Bond has a maturity of 6 years and an embedded issuer call option after 5 years. Settlement will take place on 3 September 2026 and the notes will be listed on the Luxembourg Stock Exchange’s Eur...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Marathon Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Marathon Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...